Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review
Abstract Introduction Although the introduction of biologics and targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs) has reshaped the treatment paradigm for immune-mediated inflammatory diseases (IMIDs) such as psoriasis, oral conventional synthetic DMARDs (csDMARDs) remain the corne...
Main Authors: | Tyng-Shiuan Hsieh, Tsen-Fang Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-03-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-023-00903-5 |
Similar Items
-
Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting
by: Rieke Alten, et al.
Published: (2018-01-01) -
Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis
by: Yinan Huang, et al.
Published: (2023-09-01) -
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
by: Michelle L. M. Mulder, et al.
Published: (2020-02-01) -
Disease-modifying antirheumatic drugs – Old and new: A brief overview
by: Vidya Divakar Baliga, et al.
Published: (2019-01-01) -
Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
by: Xia Y, et al.
Published: (2016-05-01)